Faron Pharmaceuticals Oy
FARN.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -£25,920 | -£30,944 | -£28,730 | -£21,194 |
| Dep. & Amort. | £315 | £346 | £300 | £307 |
| Deferred Tax | £0 | £0 | £0 | £114 |
| Stock-Based Comp. | £694 | £2,450 | £1,297 | £1,487 |
| Change in WC | -£4,598 | £3,244 | £4,766 | -£1,761 |
| Other Non-Cash | £6,538 | £1,098 | -£626 | -£1,171 |
| Operating Cash Flow | -£22,971 | -£23,806 | -£22,993 | -£22,218 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -£1 | -£123 | -£385 | -£474 |
| Net Acquisitions | £0 | £0 | £0 | £0 |
| Inv. Purchases | £0 | £0 | £0 | £0 |
| Inv. Sales/Matur. | £0 | £0 | £0 | £0 |
| Other Inv. Act. | -£225 | £0 | £0 | £1 |
| Investing Cash Flow | -£226 | -£123 | -£385 | -£473 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -£171 | -£797 | £10,284 | £540 |
| Stock Issued | £31,850 | £26,031 | £13,445 | £25,559 |
| Stock Repurch. | £0 | £0 | £0 | £0 |
| Dividends Paid | £0 | £0 | £0 | £0 |
| Other Fin. Act. | -£5,863 | -£1,251 | -£251 | -£509 |
| Financing Cash Flow | £25,816 | £23,983 | £23,478 | £25,590 |
| Forex Effect | £8 | -£168 | £37 | -£153 |
| Net Chg. in Cash | £2,627 | -£114 | £137 | £2,745 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | £6,876 | £6,990 | £6,853 | £4,108 |
| End Cash | £9,503 | £6,876 | £6,990 | £6,853 |
| Free Cash Flow | -£23,197 | -£23,929 | -£23,378 | -£22,692 |